SENPLISYME Trademark

Trademark Overview

On Thursday, March 7, 2019, a trademark application was filed for SENPLISYME with the United States Patent and Trademark Office. The USPTO has given the SENPLISYME trademark a serial number of 88329932. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 23, 2023. This trademark is owned by Genzyme Corporation. The SENPLISYME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
senplisyme

General Information

Serial Number88329932
Word MarkSENPLISYME
Filing DateThursday, March 7, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, January 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 20, 2022SOU EXTENSION 5 GRANTED
Tuesday, May 17, 2022SOU EXTENSION 5 FILED
Friday, May 20, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 17, 2022TEAS EXTENSION RECEIVED
Thursday, November 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 2, 2021SOU EXTENSION 4 GRANTED
Tuesday, November 2, 2021SOU EXTENSION 4 FILED
Tuesday, November 2, 2021TEAS EXTENSION RECEIVED
Saturday, April 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 22, 2021SOU EXTENSION 3 GRANTED
Thursday, April 22, 2021SOU EXTENSION 3 FILED
Thursday, April 22, 2021TEAS EXTENSION RECEIVED
Friday, October 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 21, 2020SOU EXTENSION 2 GRANTED
Wednesday, October 21, 2020SOU EXTENSION 2 FILED
Wednesday, October 21, 2020TEAS EXTENSION RECEIVED
Thursday, May 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 19, 2020SOU EXTENSION 1 GRANTED
Tuesday, May 19, 2020SOU EXTENSION 1 FILED
Tuesday, May 19, 2020TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 1, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 1, 2019NON-FINAL ACTION E-MAILED
Monday, April 1, 2019NON-FINAL ACTION WRITTEN
Sunday, March 31, 2019ASSIGNED TO EXAMINER
Tuesday, March 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 11, 2019NEW APPLICATION ENTERED

Related Keywords

senplisyme diseases preparations pharmaceutical treatment prevention namely infectious rare infections bacterial